Reports of Biochemistry
and Molecular Biology
Mon, Nov 18, 2024
[Archive]
Volume 9, Issue 3 (Vol.9 No.3 Oct 2020)
rbmb.net 2020, 9(3): 278-290 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sayed Abdel-Tawab M, Mostafa Tork O, Mostafa-Hedeab G, Ewaiss Hassan M, Azmy Elberry D. Protective Effects of Quercetin and Melatonin on Indomethacin Induced Gastric Ulcers in Rats. rbmb.net 2020; 9 (3) :278-290
URL: http://rbmb.net/article-1-496-en.html
URL: http://rbmb.net/article-1-496-en.html
Marwa Sayed Abdel-Tawab * 
, Ola Mostafa Tork , Gomaa Mostafa-Hedeab , Manal Ewaiss Hassan , Dalia Azmy Elberry
, Ola Mostafa Tork , Gomaa Mostafa-Hedeab , Manal Ewaiss Hassan , Dalia Azmy Elberry
Medical Biochemistry Department, Faculty of Medicine, Beni-Suef University, Egypt
Abstract: (4234 Views)
Background: Medications to prevent the development of NSAID-induced gastric ulcers have a large range of unpleasant side effects. Recent efforts have been focused on determining safer alternative non-toxic and natural forms of anti-ulcer treatments.
Methods: Twenty-four male rats were divided into 4 groups: 1: control group that received no treatment; 2: the indomethacin-treated group that received 20 mg/kg of indomethacin for 2 days to induce the development of gastric ulcers; 3: quercetin-treated group that in addition to the indomethacin treatment, received 50 mg/kg of quercetin 6 hours after and then daily for 14 days and; 4: the melatonin-treated group which received 20 mg/kg of melatonin 6 hours after each indomethacin treatment and then daily for 14 days. All drugs were administered orally. The following parameters were assessed in each group: mean ulcer index of gastric tissue, gastric acid volume and pH, oxidative stress markers: malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH), inflammatory markers: PGE-2, TNF-α, and IL-10, nitric oxide (NO) levels and the relative gene expression of BAX, BCL-2 and COX-2 by real time PCR.
Results: Our findings revealed that the indomethacin-treated group had a significantly increased (p< 0.05) ulcer index, gastric acid volume, and elevated levels of stress, inflammatory, and apoptotic markers compared to controls. In the groups that received quercetin or melatonin, these factors were all significantly decreased (p< 0.05). Between quercetin and melatonin, there was no significant difference in their gastroprotective effect.
Conclusions: Both quercetin and melatonin had protective antioxidant, anti-inflammatory and antiapoptotic activity against indomethacin-induced gastric ulcers.
Methods: Twenty-four male rats were divided into 4 groups: 1: control group that received no treatment; 2: the indomethacin-treated group that received 20 mg/kg of indomethacin for 2 days to induce the development of gastric ulcers; 3: quercetin-treated group that in addition to the indomethacin treatment, received 50 mg/kg of quercetin 6 hours after and then daily for 14 days and; 4: the melatonin-treated group which received 20 mg/kg of melatonin 6 hours after each indomethacin treatment and then daily for 14 days. All drugs were administered orally. The following parameters were assessed in each group: mean ulcer index of gastric tissue, gastric acid volume and pH, oxidative stress markers: malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH), inflammatory markers: PGE-2, TNF-α, and IL-10, nitric oxide (NO) levels and the relative gene expression of BAX, BCL-2 and COX-2 by real time PCR.
Results: Our findings revealed that the indomethacin-treated group had a significantly increased (p< 0.05) ulcer index, gastric acid volume, and elevated levels of stress, inflammatory, and apoptotic markers compared to controls. In the groups that received quercetin or melatonin, these factors were all significantly decreased (p< 0.05). Between quercetin and melatonin, there was no significant difference in their gastroprotective effect.
Conclusions: Both quercetin and melatonin had protective antioxidant, anti-inflammatory and antiapoptotic activity against indomethacin-induced gastric ulcers.
Type of Article: Original Article |
Subject:
Biochemistry
Received: 2020/04/27 | Accepted: 2020/06/8 | Published: 2020/12/1
Received: 2020/04/27 | Accepted: 2020/06/8 | Published: 2020/12/1
References
1. Tsai TC, Brooks DC. Evaluation of Peptic Ulcer Disease. In: Grams J., Perry K., Tavakkoli A. (eds) The SAGES Manual of Foregut Surgery. Springer, Cham. 2019; pp 635-642. [DOI:10.1007/978-3-319-96122-4_53]
2. Jahnavi K, Pavani Reddy P, Vasudha B, Narender B. Non-steroidal anti-inflammatory drugs: an overview. Journal of Drug Delivery and Therapeutics. 2019;9(1-s):442-448. [DOI:10.22270/jddt.v9i1-s.2287]
3. Naito Y, Yoshikawa T. Oxidative stress involvement and gene expression in indomethacin-induced gastropathy. Redox Rep. 2006;11(6):243-53. [DOI:10.1179/135100006X155021] [PMID]
4. Lichtenberger LM, Zhou Y, Dial EJ, Raphael RM. NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes. J Pharm Pharmacol. 2006;58(11): 1421-8. [DOI:10.1211/jpp.58.10.0001]
5. Jana NR. NSAIDs and apoptosis. Cell Mol Life Sci. 2008;65(9):1295-301. [DOI:10.1007/s00018-008-7511-x] [PMID]
6. Souza MH, Lemos HP, Oliveira RB, Cunha FQ. Gastric damage and granulocyte infiltration induced by indomethacin in tumor necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice. Gut. 2004;53(6):791-6. [DOI:10.1136/gut.2002.012930] [PMID] [PMCID]
7. Scarpignato C, Hunt RH. Nonsteroidal anti-inflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention. Gastroenterol Clin North Am. 2010;39(3):433-64. [DOI:10.1016/j.gtc.2010.08.010] [PMID]
8. Miederer SE. [Will anti-ulcer drugs soon differ only in their side effects?]. Fortschr Med. 1986;104(3):918-20.
9. Borrelli F1, Izzo AA. The plant kingdom as a source of anti-ulcer remedies. Phytother Res. 2000;14(8):581-91.
https://doi.org/10.1002/1099-1573(200012)14:8<581::AID-PTR776>3.0.CO;2-S [DOI:10.1002/1099-1573(200012)14:83.0.CO;2-S]
10. Yao LH, Jiang YM, Shi J, et al. Flavonoids in food and their health benefits. Plant Foods for Human Nutrition. 2004;59(3):113-122. [DOI:10.1007/s11130-004-0049-7] [PMID]
11. Mota KS, Dias GE, Pinto ME, Luiz-Ferreira A, Souza-Brito AR, Hiruma-Lima CA, Barbosa-Filho JM, Batista LM. Flavonoids with gastroprotective activity. Molecules. 2009;14(3):979-1012. [DOI:10.3390/molecules14030979] [PMID] [PMCID]
12. Kahraman A, Erkasap N, Koken T, Serteser M, Aktepe F, Erkasap S. The antioxidative and antihistaminic properties of quercetin in ethanol-induced gastric lesions. Toxicology. 2003;183(1-3):133-42. [DOI:10.1016/S0300-483X(02)00514-0]
13. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res. 2011;51(1):1-16. [DOI:10.1111/j.1600-079X.2011.00916.x] [PMID]
14. Yamasaki K, Ishiyama H, Imaizumi T, Kanbe T, Yabuuchi Y. Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Jpn J Pharmacol. 1989;49(4):441-8 [DOI:10.1016/S0021-5198(19)43019-9]
15. Noriyoshi S, Masaru Y, Takemi G, Yoshimitsu A. Stimulation of prostaglandin E2 and interleukin-1ß production from periodontal ligament cells of old rat subjected to mechanical stress. J Gerontol A Biol Sci Med Sci. 2000;55(10): B489-95. [DOI:10.1093/gerona/55.10.B489] [PMID]
16. Othman AI, El-Missiry MA, Amer MA. The protective action of melatonin on indomethacin-induced gastric and testicular oxidative stress in rats. Redox Rep. 2001;6(3):173-7. [DOI:10.1179/135100001101536283] [PMID]
17. Nishida K, Ohta Y, Ishiguro I. Relation of inducible nitric oxide synthase activity to lipid peroxidation and nonprotein sulfhydryl oxidation in the development of stress-induced gastric mucosal lesions in rats. Nitric Oxide. 1998;2(4): 215-23. [DOI:10.1006/niox.1998.0178] [PMID]
18. Peskar BM, Ehrlich K, Peskar BA. Role of ATP-sensitive potassium channels in prostaglandin-mediated gastroprotection in the rat. J Pharmacol Exp Ther. 2002;301(3):969-74. [DOI:10.1124/jpet.301.3.969] [PMID]
19. Kiernan, JA. Histological and Histochemical Methods: Theory and Practice. 3rd ed. New York & New Delhi: Arnold publisher. 2001. p. 111-162.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408. [DOI:10.1006/meth.2001.1262] [PMID]
21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-8. [DOI:10.1016/0003-2697(79)90738-3]
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. [DOI:10.1016/0003-2697(76)90527-3]
23. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980;106(1):207-12. [DOI:10.1016/0003-2697(80)90139-6]
24. Grisham MB, Johnson GG, Gautreaux MD, Berg RD. Measurement of nitrate and nitrite in extracellular fluids: A window to systemic nitric oxide metabolism. ELSEVIER. 1995;7(1):84-90. [DOI:10.1006/meth.1995.1012]
25. Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology. 2000;119(3):706-14. [DOI:10.1053/gast.2000.16510] [PMID]
26. Takeuchi K, Amagase K. Roles of Cyclooxygenase, Prostaglandin E2 and EP Receptors in Mucosal Protection and Ulcer Healing in the Gastrointestinal Tract. Curr Pharm Des. 2018;24(18):2002-2011. [DOI:10.2174/1381612824666180629111227] [PMID]
27. Alkushi AGR, Elsawy NAM. Quercetin attenuates, indomethacin-induced acute gastric ulcer in rats. Folia Morphol (Warsz). 2017;76(2):252-261. [DOI:10.5603/FM.a2016.0067] [PMID]
28. Ibrahim RM, Allam MM, El-Gohary OA, El-Talees AE, El-Hamady MS. Protective effect of obestatin on indomethacin-induced acute gastric ulcer in rats: role of VEGF and TNF-α. Benha Med J. 2018;35(3):369-377. [DOI:10.4103/bmfj.bmfj_86_18]
29. 29 Cuesta S, Kireev R, Garcia C, Forman K, Escames G, Vara E, et al. Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model. Mech Ageing Dev. 2011;132(11-12):573-82. [DOI:10.1016/j.mad.2011.10.005] [PMID]
30. Konturek SJ, Konturek PC, Brzozowski T. Melatonin in gastroprotection against stress-induced acute gastric lesions and in healing of chronic gastric ulcers. J Physiol Pharmacol. 2006;57(Suppl 5):51-66.
31. Carrasco-Pozo C, Castillo RL, Beltran C, Miranda A, Fuentes J, Gotteland M. Molecular mechanisms of gastrointestinal protection by quercetin against indomethacin-induced damage: role of NF-κB and Nrf2. J Nutr Biochem. 2016; 27:289-98. [DOI:10.1016/j.jnutbio.2015.09.016] [PMID]
32. Tanaka A, Araki H, Hase S, Komoike Y, Takeuchi K. Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury. Aliment Pharmacol Ther. 2002;16(Suppl 2):90-101. [DOI:10.1046/j.1365-2036.16.s2.22.x] [PMID]
33. Pal P, Bhattacharjee B, Chattopadhyay A. and Bandyopadhyay D. Melatonin as an armament against non-steroidal anti-inflammatory drug induced gastric injury: An overview. Melatonin Research. 2019; 2:115-137. [DOI:10.32794/mr11250015]
34. Slomiany BL, Slomiany A. Role of endothelin- converting enzyme-1 in the suppression of constitutive nitric oxide synthase in rat gastric mucosal injury by indomethacin. Scand J Gastroenterol. 2000;35(11):1131-6. [DOI:10.1080/003655200750056583] [PMID]
35. Holian O, Wahid S, Atten MJ, Attar BM. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am J Physiol Gastrointest Liver Physiol. 2002;282(5):G809-16. [DOI:10.1152/ajpgi.00193.2001] [PMID]
36. Maity P, Bindu S, Dey S, Goyal M, Alam A, Pal C, et al. Melatonin reduces indomethacin-induced gastric mucosal cell apoptosis by preventing mitochondrial oxidative stress and the activation of mitochondrial pathway of apoptosis. J Pineal Res. 2009;46(3):314-23. [DOI:10.1111/j.1600-079X.2009.00663.x] [PMID]
37. Kusuhura H, Komatsu H, Sumichika H, Sugahara K. Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells. Eur J Pharmacol. 1999;383(3):331-7. [DOI:10.1016/S0014-2999(99)00599-3]
38. Ishikawa Y, and Kitamura M. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int. 2000;58(3):1078-87. [DOI:10.1046/j.1523-1755.2000.00265.x] [PMID]
39. Refolo MG, D'Alessandro R, Malerba N, Laezza C, Bifulco M, Messa C, et al. Anti-Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines. J Cell Physiol. 2015;230(12):2973-80. [DOI:10.1002/jcp.25026] [PMID]
40. Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, et al. Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis. Sci Rep. 2016; 6:24049. [DOI:10.1038/srep24049] [PMID] [PMCID]
41. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem. 2003;278(13):10993-1001. [DOI:10.1074/jbc.M210328200] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
